13 June 2018 - The United Kingdom’s NICE publishes positive guidance for the first selective interleukin 23 inhibitor to treat moderate ...
21 March 2018 - This study examines whether real world data is incorporated in health technology assessment (HTA) of melanoma drugs ...
1 March 2018 - Significant benefits in terms of symptoms and especially in quality of life/dossier provides meaningful data. ...
19 February 2018 - Optional scientific advice for the early benefit assessment of pharmaceuticals is offered by the German decision maker, ...
18 January 2018 - Oncology remains by far the most common indication. ...
4 January 2018 - Four dossier assessments involving comparisons between immunotherapies and chemotherapies for the same therapeutic indication in 2017/comparison ...
16 January 2018 - Germany’s drug assessment body has criticized a lack of data directly comparing drugs in a promising ...
5 January 2018 - In their article in the Journal of Clinical Epidemiology, Marco Knelangen, Elke Hausner, Sibylle Sturtz, and ...
1 September 2017 - Significant benefit for patients with progression during or shortly after platinum-based therapy. ...
3 July 2017 - The anti-viral medicine tenofovir alafenamide fumarate has been used in various combinations since 2015 in HIV ...
26 June 2017 - The first ever EU antitrust probe into excessive drug pricing is taking the European pharmaceuticals industry ...
15 June 2017 - European governments should spend more on drugs if they want to keep a lid on prices, ...
1 June 2017 - The manufacturer of secukinumab has applied for a new benefit assessment as new scientific evidence emerges. ...
15 May 2017 - Patients in the relevant subpopulation of the analysed study survived longer. ...
12 April 2017 - Clinuvel today announced that it had reached agreement with the German National Association of Statutory Health ...